PRLog Home
All Businesses
All Newsrooms
Press Releases Home
Swiftmerge Acquisition Corp
About
Newsroom
Contact
Filter By Industry
Select One
Biotech
Business
Financial
Health
Science
Filter By Tag
Select One
Atherosclerosis
Cardiovascular
Cardiovasculardisease
Familial hypercholesterolemia
Healthcare
Heartattack
HoFH
Homozygous
Lipidscience
Lowattenuatedplaque
Newsroom
Swiftmerge Acquisition Corp Press releases
1 - 1 of 1 Press Release
HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp
Aug 11, 2023
$480 million Business Combination to Accelerate the Commercialization of an Innovative FDA-Approved Cardiovascular Disease Treatment
Swiftmerge Acquisition Corp RSS Feed
Share This Page
Website
Follow on Twitter